Table 3.
Characteristic | Persistent HPV (n=13) |
Overall HPV (n=92) |
Incident HPV (n=54) |
|
---|---|---|---|---|
No. (%) | No. (%) | No. (%) | p-value | |
Region | ||||
Busan | 10 (76.9) | 46 (50.0) | 42 (77.8) | < 0.001 |
Suwon | 3 (23.1) | 46 (50.0) | 12 (22.2) | |
Age group (yr) | ||||
< 39 | 2 (15.4) | 24 (26.1) | 10 (18.5) | 0.31 |
40-49 | 2 (15.4) | 35 (38.0) | 25 (46.3) | |
50-59 | 8 (61.5) | 27 (29.4) | 16 (29.6) | |
≥ 60 | 1 (7.7) | 6 (6.5) | 3 (5.6) | |
Marital status | ||||
Unmarried | 6 (46.2) | 19 (20.6) | 8 (14.8) | 0.036 |
Married | 7 (53.9) | 73 (79.4) | 46 (85.2) | |
Educational level | ||||
None/Elementary/Middle school | 9 (69.2) | 39 (42.4) | 23 (42.6) | 0.19 |
High school/University/≥ Master | 4 (30.7) | 53 (57.6) | 31 (57.4) | |
Smoking status | ||||
Nonsmoker | 12 (92.3) | 86 (95.9) | 53 (98.2) | 0.352 |
Smoker | 1 (7.7) | 6 (4.1) | 1 (1.8) | |
Alcohol drinking | ||||
No | 8 (61.5) | 58 (63.1) | 34 (62.9) | 0.201 |
Yes | 5 (38.5) | 34 (36.9) | 20 (37.1) | |
Lifetime sexual partners | ||||
1 | 8 (61.5) | 64 (70.3) | 38 (71.7) | < 0.001 |
≥ 2 | 5 (38.5) | 27 (29.7) | 15 (28.3) | |
Parity | ||||
1 | 2 (16.6) | 9 (11.1) | 6 (11.3) | 0.393 |
2 | 5 (41.7) | 47 (58.0) | 29 (54.7) | |
≥ 3 | 5 (41.7) | 25 (30.9) | 18 (34.0) | |
Hormone therapy use | ||||
Never user | 9 (100) | 31 (81.6) | 20 (83.3) | 0.478 |
Ever user | 0 | 7 (18.4) | 4 (16.7) | |
History of STD | ||||
No | 12 (100) | 85 (92.4) | 49 (90.7) | 0.078 |
Yes | 0 | 7 (7.6) | 5 (9.3) | |
Family history of cancer | ||||
No | 5 (38.5) | 57 (62.0) | 29 (53.7) | 0.021 |
Yes | 8 (61.5) | 35 (38.0) | 25 (46.3) | |
Chlamydia trachomatis at baseline | ||||
Negative | 13 (100) | 82 (90.1) | 49 (94.2) | 0.019 |
Positive | 0 | 9 (9.9) | 3 (5.8) |
HPV, human papillomavirus; STD, sexual transmitted disease.
Sample sizes for individual characteristics may not equal total due to missing values.